Fyavolv Tablet, Film Coated
Product Images NDC 68180-828

16 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fyavolv (NDC 68180-828). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (42e98704 Dee2 481c 849b E3d9439a7005 01)

Figure 1 (42e98704 Dee2 481c 849b E3d9439a7005 01)
Chemical structure of the active ingredient Ethinyl Estradiol, showing the steroidal four-ring core with hydroxyl groups and an ethynyl substituent at the 17-alpha position.*
FDA Label Image

Figure 2 (42e98704 Dee2 481c 849b E3d9439a7005 02)

Figure 2 (42e98704 Dee2 481c 849b E3d9439a7005 02)
Chemical structure of Norethindrone Acetate, the active ingredient in Fyavolv. The diagram shows the molecular framework including rings, bonds, and functional groups typical of this steroidal compound.*
FDA Label Image

Figure 3 (42e98704 Dee2 481c 849b E3d9439a7005 03)

Figure 3 (42e98704 Dee2 481c 849b E3d9439a7005 03)
A line graph showing the mean plasma norethindrone concentration (ng/mL) plotted against time (hours) over a 24-hour period. The graph illustrates a rapid increase in concentration within the first few hours, peaking near 9-10 ng/mL, followed by a gradual decline back toward baseline by 24 hours.*
FDA Label Image

Figure 4 (42e98704 Dee2 481c 849b E3d9439a7005 04)

Figure 4 (42e98704 Dee2 481c 849b E3d9439a7005 04)
A line graph depicting the mean plasma concentration of Ethinyl Estradiol (pg/mL) over time (hours). Concentrations rise sharply to a peak within the first few hours, then gradually decline over a 24-hour period, illustrating the pharmacokinetic profile of the active ingredient in Fyavolv tablets.*
FDA Label Image

Figure 5 (42e98704 Dee2 481c 849b E3d9439a7005 05)

Figure 5 (42e98704 Dee2 481c 849b E3d9439a7005 05)
A line graph comparing the percentage of patients over 12 months of treatment with Placebo, Norethindrone Acetate and Ethinyl Estradiol 0.5/2.5 mg, and Norethindrone Acetate and Ethinyl Estradiol 1/5 mg. The x-axis represents months of treatment from 1 to 12, and the y-axis shows the percentage of patients from 0 to 100. The graph includes three lines for each treatment group depicting changes in patient percentages over time.*
FDA Label Image

Figure 6 (42e98704 Dee2 481c 849b E3d9439a7005 06)

Figure 6 (42e98704 Dee2 481c 849b E3d9439a7005 06)
A bar chart titled 'Mean Percent Change From Baseline in Volumetric Bone Mineral Density at Lumbar Spine' measured by quantitative computed tomography at 12 and 24 months of treatment. It compares placebo, Norethindrone Acetate and Ethinyl Estradiol 0.5/2.5 mg, and Norethindrone Acetate and Ethinyl Estradiol 1/5 mg groups, showing mean percent change with standard error bars and statistical significance markers at both time points.*
FDA Label Image

Image (42e98704 Dee2 481c 849b E3d9439a7005 07)

FDA Label Image

Image (42e98704 Dee2 481c 849b E3d9439a7005 08)

FDA Label Image

Bottle Label (0.5 mg/0.0025 mg)

Bottle Label (0.5 mg/0.0025 mg)
Fyavolv 0.5 mg/0.0025 mg tablets film-coated oral medication label. Contains norethindrone acetate USP 0.5 mg and ethinyl estradiol USP 0.0025 mg. Manufactured by Lupin Limited, India, and distributed by Lupin Pharmaceuticals, Inc., USA. The label includes dosage instructions, storage conditions, barcode, and safety warnings. Package count is 90 tablets.*
FDA Label Image

Bottle Label (1 mg/0.005 mg)

Bottle Label (1 mg/0.005 mg)
Fyavolv 1 mg/0.005 mg film-coated tablets label from Lupin Pharmaceuticals, Inc. The label indicates the active ingredients norethindrone acetate 1 mg and ethinyl estradiol 0.005 mg per blue film-coated tablet. The package contains 90 tablets and includes storage instructions, distribution details, and contact information for reporting adverse reactions.*
FDA Label Image

Blister Label: 28 Tablets (NDC 68180-827-71)

Blister Label: 28 Tablets (NDC 68180-827-71)
Label for Fyavolv 0.5 mg/0.0025 mg film-coated tablets containing norethindrone acetate and ethinyl estradiol. The label includes storage instructions at 25°C (77°F) with excursions 15 to 30°C, NDC 68180-827-71, distributed by Lupin Pharmaceuticals, Inc., and manufactured by Lupin Limited in India. Barcode is displayed with lot and expiration placeholders.*
FDA Label Image

Pouch Label: 28 Tablets (NDC 68180-827-71)

Pouch Label: 28 Tablets (NDC 68180-827-71)
Packaging label for Fyavolv tablets containing norethindrone acetate and ethinyl estradiol, strength 0.5 mg/0.0025 mg. The label indicates 1 blister pack with 28 film-coated oral tablets. It is distributed by Lupin Pharmaceuticals, Inc. in the United States and manufactured in India by Lupin Limited. The label includes storage instructions, a pregnancy warning, and states the product is Rx only.*
FDA Label Image

Carton Label: 3 Blister Of 28 Tablets Each (NDC 68180-827-73)

Carton Label: 3 Blister Of 28 Tablets Each (NDC 68180-827-73)
Packaging label for Fyavolv 0.5 mg/0.0025 mg film-coated tablets, containing norethindrone acetate and ethinyl estradiol. The carton states it contains 3 blisters of 28 tablets each. Distributed by Lupin Pharmaceuticals, Inc., with manufacturing in India by Lupin Limited.*
FDA Label Image

Blister Label: 28 Tablets (NDC 68180-828-71)

Blister Label: 28 Tablets (NDC 68180-828-71)
Fyavolv 1 mg/0.005 mg tablets, film-coated oral tablets containing norethindrone acetate and ethinyl estradiol. The label shows storage instructions, distributor Lupin Pharmaceuticals, Inc. in Naples, FL, and manufacturer Lupin Limited in India. The label includes a barcode and mentions the lot number and expiration date fields.*
FDA Label Image

Pouch Label: 28 Tablets (NDC 68180-828-71)

Pouch Label: 28 Tablets (NDC 68180-828-71)
The packaging label for Fyavolv 1 mg/0.005 mg tablets features Norethindrone Acetate and Ethinyl Estradiol as active ingredients. The film-coated oral tablets come in a blister pack containing 28 tablets. The product is distributed by Lupin Pharmaceuticals, Inc., USA, and manufactured in India. The label includes dosage instructions, storage details, and a child-resistant warning.*
FDA Label Image

Carton Label: 3 Blister Of 28 Tablets Each (NDC 68180-828-73)

Carton Label: 3 Blister Of 28 Tablets Each (NDC 68180-828-73)
Packaging label for Fyavolv tablets, containing norethindrone acetate and ethinyl estradiol, 1 mg/0.005 mg. The label indicates a film-coated oral tablet formulation distributed by Lupin Pharmaceuticals, Inc. It includes packaging details for 3 blisters of 28 tablets each, marked Rx only, with barcode and manufacturing information by Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.